Cargando…
A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507345/ https://www.ncbi.nlm.nih.gov/pubmed/32997418 http://dx.doi.org/10.1002/ctm2.170 |
| _version_ | 1783585208675598336 |
|---|---|
| author | Xu, Shengchao Tang, Lu Dai, Gan Luo, Chengke Liu, Zhixiong |
| author_facet | Xu, Shengchao Tang, Lu Dai, Gan Luo, Chengke Liu, Zhixiong |
| author_sort | Xu, Shengchao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7507345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75073452020-09-28 A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma Xu, Shengchao Tang, Lu Dai, Gan Luo, Chengke Liu, Zhixiong Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-09-17 /pmc/articles/PMC7507345/ /pubmed/32997418 http://dx.doi.org/10.1002/ctm2.170 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Xu, Shengchao Tang, Lu Dai, Gan Luo, Chengke Liu, Zhixiong A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| title | A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| title_full | A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| title_fullStr | A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| title_full_unstemmed | A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| title_short | A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| title_sort | novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507345/ https://www.ncbi.nlm.nih.gov/pubmed/32997418 http://dx.doi.org/10.1002/ctm2.170 |
| work_keys_str_mv | AT xushengchao anovelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT tanglu anovelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT daigan anovelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT luochengke anovelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT liuzhixiong anovelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT xushengchao novelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT tanglu novelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT daigan novelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT luochengke novelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma AT liuzhixiong novelgenesignaturepredictschemoradiotherapyefficacyandtumorimmunityinhighgradeglioma |